JP2008510683A5 - - Google Patents

Download PDF

Info

Publication number
JP2008510683A5
JP2008510683A5 JP2007522011A JP2007522011A JP2008510683A5 JP 2008510683 A5 JP2008510683 A5 JP 2008510683A5 JP 2007522011 A JP2007522011 A JP 2007522011A JP 2007522011 A JP2007522011 A JP 2007522011A JP 2008510683 A5 JP2008510683 A5 JP 2008510683A5
Authority
JP
Japan
Prior art keywords
group
technetium complex
following formula
formula
conr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007522011A
Other languages
English (en)
Japanese (ja)
Other versions
JP5557425B2 (ja
JP2008510683A (ja
Filing date
Publication date
Priority claimed from GBGB0416062.8A external-priority patent/GB0416062D0/en
Application filed filed Critical
Publication of JP2008510683A publication Critical patent/JP2008510683A/ja
Publication of JP2008510683A5 publication Critical patent/JP2008510683A5/ja
Application granted granted Critical
Publication of JP5557425B2 publication Critical patent/JP5557425B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2007522011A 2004-07-19 2005-07-19 改良n4キレーターコンジュゲート Expired - Lifetime JP5557425B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0416062.8A GB0416062D0 (en) 2004-07-19 2004-07-19 Improved N4 chelator conjugates
GB0416062.8 2004-07-19
PCT/GB2005/002807 WO2006008496A2 (en) 2004-07-19 2005-07-19 Improved n4 chelator conjugates

Publications (3)

Publication Number Publication Date
JP2008510683A JP2008510683A (ja) 2008-04-10
JP2008510683A5 true JP2008510683A5 (enExample) 2008-09-04
JP5557425B2 JP5557425B2 (ja) 2014-07-23

Family

ID=32893775

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007522011A Expired - Lifetime JP5557425B2 (ja) 2004-07-19 2005-07-19 改良n4キレーターコンジュゲート

Country Status (14)

Country Link
US (1) US7767796B2 (enExample)
EP (1) EP1768708B1 (enExample)
JP (1) JP5557425B2 (enExample)
KR (2) KR20130024963A (enExample)
CN (1) CN101128219B (enExample)
AU (1) AU2005263942B2 (enExample)
BR (1) BRPI0513456A (enExample)
CA (1) CA2573384C (enExample)
ES (1) ES2628935T3 (enExample)
GB (1) GB0416062D0 (enExample)
MX (1) MX2007000744A (enExample)
NO (1) NO20070348L (enExample)
RU (1) RU2360701C2 (enExample)
WO (1) WO2006008496A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI448284B (zh) * 2007-04-24 2014-08-11 Theravance Inc 雙效抗高血壓劑
CN101732736B (zh) * 2009-12-02 2012-04-04 北京师范大学 制备锝-99m标记的DTPA-LSA的药盒及制备方法和应用
GB0922014D0 (en) 2009-12-17 2010-02-03 Ge Healthcare Ltd Novel integrin binders
GB201016206D0 (en) * 2010-09-27 2010-11-10 Ge Healthcare Ltd Apoptosis imaging agents
RU2465011C1 (ru) * 2011-04-27 2012-10-27 Общество с ограниченной ответственностью "ИНТЕРА-МЕД" Радиофармацевтический препарат для диагностики меланомы и ее метастазов
GB201110767D0 (en) 2011-06-24 2011-08-10 Ge Healthcare Ltd Infection imaging
GB201600161D0 (en) * 2016-01-05 2016-02-17 Bayer As Isotope purification method
RU2655392C1 (ru) * 2017-03-02 2018-05-28 Федеральное государственное автономное образовательное учреждение высшего образования "Национальный исследовательский Томский политехнический университет" Способ получения комплекса технеция-99м с октреотидом для диагностики нейроэндокринных опухолей
CN112105393A (zh) 2018-05-16 2020-12-18 爱默蕾大学 苯乙烯基苯并噻唑衍生物及在成像中的用途

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242679A (en) * 1985-01-14 1993-09-07 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
ATE66469T1 (de) * 1985-01-14 1991-09-15 Neorx Corp Metall-radionuklid markiertes protein fuer diagnose und therapie.
US5175343A (en) * 1985-01-14 1992-12-29 Neorx Corporation Metal radionuclide labeled proteins for diagnosis and therapy
JPH02504387A (ja) * 1987-04-02 1990-12-13 セントカー・カーデイオバスキユラー・イメージング・パートナーズ・エルピー 金属イオンで抗体を標識付けする方法
US5053493A (en) * 1987-04-02 1991-10-01 Centocor Cardiovascular Imaging Partners, L.P. Method for labeling antibodies with a metal ion
US4952393A (en) * 1987-04-02 1990-08-28 The General Hospital Corporation Organ infarct imaging with technetium labelled glucarate
US5489425A (en) * 1987-06-24 1996-02-06 The Dow Chemical Company Functionalized polyamine chelants
US4994560A (en) 1987-06-24 1991-02-19 The Dow Chemical Company Functionalized polyamine chelants and radioactive rhodium complexes thereof for conjugation to antibodies
US5849261A (en) * 1991-02-08 1998-12-15 Diatide, Inc. Radiolabeled vasoactive intestinal peptides for diagnosis and therapy
NZ250653A (en) * 1993-01-12 1995-12-21 Sandoz Ltd Somatostatin derivatives and pharmaceutical or diagnostic imaging compositions
US5650134A (en) * 1993-01-12 1997-07-22 Novartis Ag (Formerly Sandoz Ltd.) Peptides
EP0857071A1 (en) * 1995-09-18 1998-08-12 Mallinckrodt Medical, Inc. (radio) labelled biotin derivatives
GR1003661B (el) * 2000-05-25 2001-09-05 Εθνικο Κεντρο Ερευνας Φυσικων Επιστημων (Εκεφε) "Δημοκριτος"... ΣΥΝΘΕΣΗ, ΒΙΟΛΟΓΙΚΗ ΚΑΙ ΠΡΟΚΛΙΝΙΚΗ ΑΞΙΟΛΟΓΗΣΗ ΑΝΑΛΟΓΩΝ ΤΗΣ (D-Phe6, Leu-NHEt13, des-Met14)-ΒΟΜΒΕΣΙΝΗΣ (6-14)ΤΡΟΠΟΠΟΙΗΜΕΝΩΝ ΜΕ ΠΑ ΡΑΓΩΓΑ ΤΟΥ 1,4,8,11-ΤΕΤΡΑΑΖΑΕΝΔΕΚΑΝΙΟΥ(1,4,8,11-TETRAAZAUNDECAN E)ΚΑΙ ΕΠΙΣΗΜΑΣΜΕΝΩΝ ΜΕ ΤΕΧΝΗΤΙΟ-99M- ΓΙΑ ΕΦΑΡΜΟΓΗ ΣΤΗΝ ΟΓΚΟΛΟΓ
EP1404371B1 (en) * 2001-07-10 2019-03-13 GE Healthcare UK Limited Peptide-based compounds for targeting intergin receptors
GB0116815D0 (en) * 2001-07-10 2001-08-29 Nycomed Amersham Plc Improved chelator conjugates
GB0130305D0 (en) * 2001-12-19 2002-02-06 Amersham Plc Compounds for imaging alzheimers disease
US7785566B2 (en) * 2003-11-06 2010-08-31 Ge Healthcare, Inc. Pharmaceutical compounds
JP2007512321A (ja) * 2003-11-24 2007-05-17 ジーイー・ヘルスケア・アクスイェ・セルスカプ 造影剤
EP1729823B1 (en) * 2004-03-04 2009-11-04 GE Healthcare AS Conjugates of angiotensin peptidic analogues and chelating agents for diagnosis and therapy

Similar Documents

Publication Publication Date Title
JP2005532287A5 (enExample)
BR0014116A (pt) Uso de um composto, composto, métodos para preparação de um composto, e para inibir aurora 2 quinase em um animal de sangue quente, e, composição farmacêutica
JP2004516314A5 (enExample)
JP2013507423A5 (enExample)
EP1862458A3 (en) Therapeutic agents useful for treating pain
WO2007048066A3 (en) Pyrazolo-pyrimidines as casein kinase ii (ck2) modulators
JP2015510886A5 (enExample)
JP2009541289A5 (enExample)
JP2014515406A5 (enExample)
JP2014518882A5 (enExample)
JP2006507265A5 (enExample)
WO2005079391A3 (en) Contrast agents for myocardial perfusion imaging
CA2591867A1 (en) Cooling topical patch preparation
DK2041133T3 (da) Derivater af imadazol [1,2-A] pyridine-2-carboxamider, fremstilling deraf og anvendelse deraf i terapeutik
JP2008510683A5 (enExample)
EP2253333A3 (en) Contrast Agents for Myocardial Perfusion Imaging
JP2004525888A5 (enExample)
PE20061319A1 (es) Cristales formados de clorhidrato de {[(2r)-7-(2,6-diclorofenil)-5-fluoro-2-3-dihidro-1-benzofurano-2-il]metil}amina
RU2003134629A (ru) Соединения цефема
EP1857459A3 (en) Pyrazolopyrimidine compound and a process for preparing the same
RU2000125889A (ru) Замещенные бисиндолималеимиды, предназначенные для ингибирования пролиферации клеток
GEP20104964B (en) 3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof
WO2003051848A3 (en) Imidazolidineacetic acid derivatives
RU2007101515A (ru) Совершенствованные конъюгаты n4 хелатообразующих агентов
MXPA05009607A (es) Derivados de n-fenil-[(4-piridil)-azinil]-amina como agentes protectores de plantas.